newzzz
Back to recent news

News Archive

Past news

DiaSorin Molecular CE marks their new Simplexa™ Flu A/B & RSV Direct Gen II Assay to run with the Simplexa™ COVID-19 Direct assay

Cypress, Calif. (July 7, 2020) – DiaSorin Molecular LLC announced today that it has CE marked its Simplexa™ Flu A/B & RSV Direct Gen II kit….

DiaSorin Molecular’s Simplexa™ Congenital CMV Direct Assay Attains CE Mark

Cypress, Calif. (June 15, 2020) – DiaSorin Molecular LLC announced today that it has received CE marking for its Simplexa™ Congenital CMV Direct kit. The new molecular diagnostic test enables direct detection of cytomegalovirus DNA in both saliva swab and urine specimens from babies up to 21 days old….

News Story: DiaSorin Molecular Has Attained CE Marking for COVID-19 Test

Cypress, Calif. (April 1, 2020) – DiaSorin Molecular LLC announced today that it has attained CE Marking for their Simplexa™ COVID-19 Direct kit, a sample-to-answer test for the detection of SARS-CoV-2,…

DiaSorin Molecular COVID-19 Test Has Received FDA Emergency Use Authorization

Cypress, Calif. (March 20, 2020) – DiaSorin Molecular LLC announced today that it has received Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit….

DiaSorin Molecular to Receive BARDA Funding to Develop a Rapid COVID-19 Test

Cypress, Calif. (March 13, 2020) – DiaSorin Molecular LLC announced today that it will receive federal funds from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S….